Novo Nordisk Foundation Commits $60 Million to CARB-X for Antibiotic Resistance Research
Rapid Read

Novo Nordisk Foundation Commits $60 Million to CARB-X for Antibiotic Resistance Research

What's Happening? The Novo Nordisk Foundation has renewed its partnership with the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), committing an additional $60 million in funding over the next four years. This new commitment builds on an initial $25 million grant in 2
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.